ValueScreener

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)

An exchange-traded fund listed on NASDAQ. A fund is not a company: it has no filed accounts of its own here, and it is never ranked beside companies. Every figure below is market data, with the day it was supplied.

Price

Last close 29.23 USD on Oct 15, 2026. Market data, supplied Oct 15, 2026.

Weekly closes, Nov 28, 2025 (25.13) to Oct 15, 2026 (29.23). Market data, supplied Oct 16, 2026.

What it costs

Expense ratio0.13%
Assets under management1.04B USD
Net asset value per share27.91 USD
InceptionNov 24, 2025
SponsorPortfolio Building Block ETFs
Asset classEquity
Holdings the fund reports0

Market data, supplied Oct 15, 2026.

What it holds

The largest 25 by weight of the 57 holdings in the snapshot of Oct 15, 2026. A fund is marked as a fund, and a holding that is not a company's share (a bond, a bill, cash, an option or a swap) is marked as not a company.

#HoldingWeight
1ELI LILLY & CO15.65%
2JOHNSON & JOHNSON9.52%
3ABBVIE INC7.71%
4MERCK & CO. INC.5.57%
5ROCHE HOLDING AG4.87%
6ASTRAZENECA PLC4.51%
7AMGEN INC4.36%
8NOVARTIS AG-REG4.14%
9GILEAD SCIENCES INC3.98%
10PFIZER INC3.51%
11VERTEX PHARMACEUTICALS INC2.66%
12NOVO NORDISK A/S-B2.66%
13BRISTOL-MYERS SQUIBB CO2.51%
14GSK PLC1.88%
15SANOFI1.86%
16MODERNA INC1.65%
17REGENERON PHARMACEUTICALS1.62%
18CSL LTD1.34%
19TAKEDA PHARMACEUTICAL CO LTD1.27%
20NATERA INC1.16%
21ARGENX SE1.10%
22BAYER AG-REG1.06%
23TEVA PHARMACEUTICAL IND LTD1.04%
24ILLUMINA INC0.89%
25SANDOZ GROUP AG0.76%

Market data, supplied Oct 15, 2026.

Sector weights

n/a. Not supplied for this fund.

Country weights

United States67.35%
Other9.98%
Switzerland5.16%
United Kingdom5.08%
Japan3.87%
France1.86%
Germany1.51%
Australia1.35%
Netherlands1.10%
Israel1.04%
Belgium0.58%
Denmark0.48%
Bermuda0.35%
Ireland0.29%

Market data, supplied Oct 15, 2026.

Look-through value

Earnings yield, P/E and book yield of the holdings taken together: n/a. Look-through figures are not measured for this fund yet.

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map
  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.